Aspiriant LLC’s Vanguard Dividend Appreciation ETF VIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205M Buy
955,149
+1,122
+0.1% +$250K 5.85% 6
2025
Q4
$210M Sell
954,027
-14,506
-1% -$3.17M 6.02% 6
2025
Q3
$209M Buy
968,533
+4,469
+0.5% +$938K 6.39% 5
2025
Q2
$197M Buy
964,064
+9,151
+1% +$1.77M 6.27% 6
2025
Q1
$185M Buy
954,913
+3,483
+0.4% +$693K 6.43% 6
2024
Q4
$186M Sell
951,430
-17,352
-2% -$3.46M 6.73% 6
2024
Q3
$192M Buy
968,782
+66
+0% +$12.6K 7.28% 5
2024
Q2
$177M Buy
968,716
+6,312
+0.7% +$1.14M 7.21% 5
2024
Q1
$176M Sell
962,404
-10,604
-1% -$1.86M 7.27% 5
2023
Q4
$166M Buy
973,008
+22,956
+2% +$3.69M 7.47% 4
2023
Q3
$148M Sell
950,052
-1,050
-0.1% -$170K 7.55% 4
2023
Q2
$154M Sell
951,102
-4,781
-0.5% -$749K 7.81% 4
2023
Q1
$147M Sell
955,883
-27,774
-3% -$4.25M 7.71% 4
2022
Q4
$149M Sell
983,657
-354,606
-26% -$52.9M 7.61% 4
2022
Q3
$181M Buy
1,338,263
+285,220
+27% +$42.4M 8.85% 3
2022
Q2
$151M Buy
1,053,043
+314,029
+42% +$47.8M 7.29% 4
2022
Q1
$120M Buy
739,014
+32,519
+5% +$5.25M 6.59% 4
2021
Q4
$121M Buy
706,495
+29,786
+4% +$4.91M 6.49% 4
2021
Q3
$104M Buy
676,709
+34,392
+5% +$5.48M 6.1% 4
2021
Q2
$99.4M Buy
642,317
+54,846
+9% +$8.42M 5.62% 4
2021
Q1
$86.4M Sell
587,471
-6,126
-1% -$871K 5.52% 4
2020
Q4
$83.8M Buy
593,597
+30,187
+5% +$4.09M 5.72% 4
2020
Q3
$72.5M Buy
563,410
+63,975
+13% +$8.05M 5.67% 3
2020
Q2
$58.5M Sell
499,435
-8,362
-2% -$952K 5.43% 3
2020
Q1
$52.5M Buy
507,797
+45,490
+10% +$5.43M 5.17% 5
2019
Q4
$57.6M Buy
462,307
+10,302
+2% +$1.25M 5.33% 2
2019
Q3
$54.1M Buy
452,005
+6,160
+1% +$727K 4.84% 2
2019
Q2
$51.3M Buy
445,845
+11,043
+3% +$1.24M 4.28% 5
2019
Q1
$47.7M Buy
434,802
+10,234
+2% +$1.08M 3.89% 5
2018
Q4
$41.6M Buy
424,568
+17,612
+4% +$1.84M 3.15% 7
2018
Q3
$45M Sell
406,956
-601
-0.1% -$64.6K 3.85% 4
2018
Q2
$41.4M Sell
407,557
-12,245
-3% -$1.25M 3.55% 4
2018
Q1
$42.4M Buy
419,802
+306,664
+271% +$31.8M 3.7% 4
2017
Q4
$11.5M Sell
113,138
-317,283
-74% -$31.2M 3.39% 10
2017
Q3
$40.8M Sell
430,421
-1,734
-0.4% -$162K 3.42% 5
2017
Q2
$40M Buy
432,155
+98,720
+30% +$9.06M 3.48% 5
2017
Q1
$30M Buy
333,435
+312,053
+1,459% +$27.7M 2.55% 10
2016
Q4
$1.82M Buy
21,382
+2,385
+13% +$201K 0.16% 80
2016
Q3
$1.59M Buy
18,997
+15,532
+448% +$1.32M 0.16% 80
2016
Q2
$272K Sell
3,465
-4,920
-59% -$402K 0.03% 161
2016
Q1
$682K Buy
+8,385
New +$643K 0.07% 117

Other funds holding VIG

Aspiriant LLC's VIG Position: Q1 2026 in Review

Aspiriant LLC increased its Vanguard Dividend Appreciation ETF (VIG) stake by 0.12% in Q1 2026, buying an estimated $250K and bringing the position to 955,149 shares worth $205M. The position accounts for 5.85% of the portfolio, ranked #6.

Aspiriant LLC first reported a position in VIG in Q1 2016 and has held it in 41 quarters since. The position peaked at $210M in Q4 2025. 2,512 funds tracked by Wall St. Rank hold VIG as of Q1 2026.

  • Aspiriant LLC held 955,149 shares of Vanguard Dividend Appreciation ETF worth $205M as of Q1 2026.
  • Aspiriant LLC bought 1,122 Vanguard Dividend Appreciation ETF shares in Q1 2026, an estimated $250K.
  • Vanguard Dividend Appreciation ETF made up 5.85% of Aspiriant LLC's portfolio in Q1 2026, its #6 holding.
  • Aspiriant LLC first reported a position in Vanguard Dividend Appreciation ETF in Q1 2016 and has held it in 41 quarters since.
  • Aspiriant LLC's Vanguard Dividend Appreciation ETF position peaked at $210M in Q4 2025.
  • 2,512 funds tracked by Wall St. Rank held Vanguard Dividend Appreciation ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.